M&A Slips Into Hyperdrive Mode
M&A activity appears to have slipped into hyperdrive mode recently and biotech M&A activity appears to be leading the way. We saw 26 new deals worth $112 billion announced just in the month of October. And the month ended with a bang. The $4.9 billion acquisition of obesity therapy company Metsera (MTSR) by Pfizer (PFE) ran…